Kairon Labs and Solidus Labs Partner to Redefine Ethical Market Making Under MiCA
12.12.2024 15:00:00 CET | Business Wire | Press release
Kairon Labs, a leading crypto market maker and liquidity provider, has partnered with Solidus Labs, a pioneer in crypto-native compliance and risk management solutions, to strengthen its compliance program and ensure readiness for the European Union's upcoming Markets in Crypto-Assets Regulation (MiCA).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241212677489/en/
Solidus Labs enters partnership with Kairon Labs (Graphic: Business Wire)
With a proven track record of supporting over 500 digital asset issuers across more than 100 exchanges, Kairon Labs is committed to ethical market-making practices that promote transparency and fairness in the crypto space. By integrating Solidus Labs' trade surveillance technology, Kairon Labs aims to proactively monitor and mitigate market manipulation risks across its operations, reinforcing its dedication to market integrity.
"As regulatory environments become increasingly stringent, it's imperative to uphold the highest standards of compliance," said Jens Willemen, Co-Founder and CEO of Kairon Labs. "Solidus Labs has proven to be the ideal partner for us, thanks to their unmatched expertise in trade surveillance and profound comprehension of the cryptocurrency landscape, especially in the context of the Markets in Crypto-Assets (MiCA) regulation. Their advanced detection algorithms, combined with a holistic compliance platform, align seamlessly with our vision of ensuring a secure trading environment for our clients while maintaining market integrity at every level."
Solidus Labs, a trusted partner for institutions dedicated to crypto integrity, provides Kairon Labs with a robust market integrity toolkit. From real-time anomaly detection to precision-driven behavioral insights, this collaboration will enable thorough monitoring and effective detection of suspicious activities across Kairon’s operations.
"By championing transparency, innovation, and trust, Kairon Labs is shaping the future—one where markets aren’t just made—they’re made better," said Asaf Meir, CEO and Founder of Solidus Labs. "With Solidus, they’re not just prepared for MiCA—they’re setting the gold standard for safe, forward-looking market making. Together, we’re building the foundation for the financial markets of tomorrow."
With MiCA’s sweeping anti-market abuse mandates set to take effect on December 30, 2024, the timing of this collaboration couldn’t be more pivotal. Kairon Labs is demonstrating that in market making, liquidity flows to safety and that market integrity is not just a responsibility—it’s a competitive advantage.
About Kairon Labs:
Kairon Labs is a premier crypto market maker and liquidity provider, offering bespoke algorithmic trading solutions to digital asset issuers. With a focus on ethical market-making practices, Kairon Labs has supported over 500 clients, ensuring successful token launches and sustained market stability. For more information, visit: Kairon Labs
About Solidus Labs
Solidus Labs is the category-definer for crypto-native security and compliance solutions: trade surveillance, transaction monitoring, and staking guard. Solidus Labs leads initiatives like the Crypto Market Integrity Coalition and the DACOM Summit, with a commitment to safe crypto trading across centralized and decentralized markets. For more information, visit: https://soliduslabs.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241212677489/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Medical University of Graz Enrolls First Patient in DEEPER CHALLENGE Trial Evaluating Spur® Peripheral Retrievable Scaffold System in a Select CLTI Cohort2.7.2026 13:00:00 CEST | Press release
Reflow Medical, Inc. announces that the Medical University of Graz has enrolled the first patient in the DEEPER CHALLENGE clinical trial. This investigator-initiated, single-center, single-arm, prospective study, supported by a grant, investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701995624/en/ The study investigates early vessel recoil following below-the-knee treatment using the Spur® Peripheral Retrievable Scaffold System in combination with a commercially available drug-coated balloon. The study plans to enroll up to 40 patients with chronic limb-threatening ischemia (CLTI) across two distinct cohorts: patients with diabetes and patients with end-stage renal disease receiving hemodialysis for at least six months, with women comprisi
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)2.7.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to eight newly hired non-executive employees. The equity awards were granted on July 1, 2026 and consisted of options to purchase an aggregate of 63,685 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 30,300 shares. The options have an exercise price per share equal to $13.29, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted sh
Infobip Launches PitchMate — An AI Fan Companion for Global Football2.7.2026 12:00:00 CEST | Press release
Two AI agents. Two global sports. One platform redefining what it means to be a fan. Global AI-first cloud communications platform Infobip launched PitchMate, a new AI-powered conversational agent that brings football fans closer to the action of the world’s biggest football tournament. Purpose-built for the global football audience, PitchMate joins the TGR Haas F1 Team RaceMate — Infobip’s AI fan engagement solution for the TGR Haas F1 Team — in demonstrating how conversational AI is transforming fan engagement across sports worldwide. RaceMate, launched last April for this year’s motorsport season, is an AI agent on WhatsApp and Apple Messages for Business that puts TGR Haas F1 Team fans at the center of the action. It delivers real-time race data, personalized content, team radio highlights, trivia, and native multilingual support, turning passive viewers into active participants through natural, human-like conversations across every race weekend. Since its launch, RaceMate has reac
Besins Healthcare Strengthens Innovation Capabilities with Acquisition of UniD Manufacturing, a Specialist in Long-Acting Drug Delivery Technologies2.7.2026 11:00:00 CEST | Press release
Acquisition brings together Besins Healthcare's hormonal health leadership and UniD's expertise in the development and manufacturing of advanced polymer based pharmaceutical formulations.1UniD Manufacturing to become Besins Healthcare PharmTech, serving as a strategic innovation hub within the company while continuing to serve its clients. Besins Healthcare, a global pharmaceutical company specializing in hormonal health, today announced the acquisition of UniD Manufacturing, a Belgium-based pharmaceutical development and manufacturing company with more than 20 years of recognized expertise in long-acting drug delivery technologies.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260701779777/en/ Besins Healthcare Strengthens Innovation Capabilities with Acquisition of UniD Manufacturing, a Specialist in Long-Acting Drug Delivery Technologies This acquisition brings together two highly compatible areas. Besins Healthcare bri
ROYC Selected by Slättö as Structuring and Platform Solution for Luxembourg Feeder Fund2.7.2026 10:45:00 CEST | Press release
ROYC, a leading global structuring and platform provider, today announced that Slättö, a Nordic private markets real estate firm, has selected ROYC to establish and manage a Luxembourg-domiciled feeder fund designed to efficiently aggregate individual subscriptions from professional investors. The Luxembourg-domiciled vehicle will be fully structured and administered on ROYC’s proprietary platform, delivering investors a seamless digital experience with real-time portfolio access, automated reporting, and efficient global distribution. ROYC streamlines onboarding and governance, standardizes legal documentation, and broadens access to capital. “Private markets are undergoing a structural shift as global banks and wealth platforms increasingly seek efficient access to high-quality private equity strategies. By combining our deep structuring expertise with ROYC’s digital operating infrastructure, we enable leading managers like Slättö to launch investor-ready vehicles rapidly while deliv
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom